Benjamin Spiller
-
Vanderbilt biomedical research paves the way for ‘hypoallergen’ treatments against peanut allergies
A recent pair of papers from the Vanderbilt University labs of Benjamin Spiller, associate professor of pharmacology, and Scott Smith, associate professor of medicine, dig into how peanut allergies are provoked and providing support for the use of a potential treatment option: hypoallergens. Both papers were published in February in the Journal of Allergy and Clinical Immunology. Read MoreFebruary 26, 2025
-
Versatile C. difficile blocker
New research reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, suggesting new therapeutic approaches. Read MoreJanuary 26, 2018
-
How to trick a wily virus
Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus. Read MoreJuly 24, 2015
-
Bacterial secretion machinery: 3-D view
New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells. Read MoreDecember 11, 2014